Navigation Links
Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
Date:4/16/2008

SAN DIEGO and SUNNYVALE, Calif., April 16 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today presented preclinical results demonstrating the anti-tumor activity of PCI-27483, the company's small-molecule Factor VIIa inhibitor. The data were presented during the Annual Meeting of the American Association for Cancer Research (AACR) being held this week in San Diego, CA.

Researchers reported that in animal models of human pancreatic tumors, treatment with PCI-27483 led to inhibition of tumor growth. PCI-27483 was administered twice daily at either 60 mg/kg or 90 mg/kg, resulting in 42 percent and 85 percent inhibition of tumor growth, respectively, after 15 days of treatment. Additional mechanistic studies showed that PCI-27483 blocked key tumor growth signals. Previous work has shown significant growth inhibition in lung and colorectal cancer models. Pharmacyclics anticipates filing an IND for PCI-27483 in the second half of 2008.

"These results support our IND-enabling studies for use of PCI-27483 in treatment of cancer and to protect against associated thromboembolic diseases," said David J. Loury, Ph.D., vice president of preclinical studies for Pharmacyclics. "These findings indicate that Factor VIIa inhibition is potentially a novel treatment approach for patients whose tumors depend on Factor VIIa activity for progression."

Factor VII is a blood protein involved in clotting. Many types of cancer, such as lung, breast, pancreatic, colorectal, gastric and others, express high levels of a cell surface protein known as tissue factor. After binding to tissue factor, Factor VII becomes activated and triggers a host of physiologic processes that facilitate the growth, invasion and spread of many tumors, a
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
4. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
5. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
6. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
7. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
8. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
9. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
10. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
11. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 NSHOA ... HRTX ) today announced positive, top-line results from ... evaluated the efficacy and safety of the Company,s ... ® (granisetron injection, extended release) as part ... neurokinin-1 (NK 1 ) receptor antagonist fosaprepitant and ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
(Date:6/1/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company ... new orphan drug indications, announced that it will be ... today, June 1, 2015, at 5:30 p.m. CDT (6:30 ... its Phase I/II study of VAL-083 (dianhydrogalactitol) ...
Breaking Medicine Technology:New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 2DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 3DelMar Pharmaceuticals to Host Investor Conference Call on June 1, 2015 to Discuss New VAL-083 Phase I/II Clinical Data in Patients with Refractory Glioblastoma Multiforme 4
... study findsLAS VEGAS, Feb. 25 Hispanic and African-American ... hip or knee replacement surgery, according to a new ... the American Academy of Orthopaedic Surgeons (AAOS) ... preoperative joint function than male patients across ethnic groups."Studies ...
... common orthopaedic conditionsLAS VEGAS, Feb. 25 The Kappa ... (OREF) presented four research awards to scientists who are ... at the 2009 Annual Meeting of the American ... . Award winners have been working towards new ...
Cached Medicine Technology:When to Have That Joint Replacement? 2When to Have That Joint Replacement? 3Applying Clinical Findings to the Practice of Medicine 2Applying Clinical Findings to the Practice of Medicine 3Applying Clinical Findings to the Practice of Medicine 4Applying Clinical Findings to the Practice of Medicine 5
(Date:6/1/2015)... 2015 Rio Salado College’s Dental Clinic ... young adults this summer. , The clinics take place Friday, ... 3 p.m. at the Rio Salado Dental Clinic. The clinic ... “A big goal for us is to offer services to ... students,” said Nikki Shipp, Clinical Coordinator for Rio’s dental hygiene. ...
(Date:6/1/2015)... The Muscular Dystrophy Association is ... participating in the sold out 2015 Bank of ... guaranteed entry by signing up through the organization's ... is limited. , This national endurance program includes ... abilities, and a supportive community of teammates, volunteers, ...
(Date:6/1/2015)... June 01, 2015 Cambia Health ... today a new, interactive Affordable Care Act (ACA) ... The course, called “Affordable Care Act Expert Series, ... the strategic and consultative insights necessary to effectively ... navigate the impacts of the ACA. , The ...
(Date:6/1/2015)... June 01, 2015 Sharenote, a leading ... for the Healthcare Industry this week in Louisiana. The ... in four days to provide potential providers with the ... profitability, and monitor risk within their network. , ... and is being used by more than 250 practices. ...
(Date:6/1/2015)... Florida (PRWEB) June 01, 2015 KC ... generously donated $88,000 of the best superfood products ... the record-breaking floods in Texas. , "Monica and ... and Natural News in distributing Living Fuel Super Meals ... of the millennial floods in Texas," KC Craichy said. ...
Breaking Medicine News(10 mins):Health News:Kids Receive Complimentary Dental Services at Rio Salado Dental Clinic 2Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3
... $25 Tickets Available for Purchase at the Pine Avenue ... Entrance to the Long Beach Convention Center, LOS ANGELES, Oct. ... Village event tonight from 5:00 p.m. to 9:00 p.m.,at the Long ... at The Village will,transform the Long Beach Convention Center,s exhibit hall ...
... ANGELES, Oct. 21 Vista Partners announced today,that ... MNOV ) and,maintains its $8.50 price. "MediciNova ... approved, will garner a sizable,percentage of the asthma ... in sales for MediciNova. Medicinova,s other clinical,candidate, MN-166, ...
... Celebration of 60 Years: Benefits St. Jude ... Children,s Research Hospital(R), ... of the game of SCRABBLE, Hasbro Inc. is auctioning,off a ... Swarovski crystals to benefit St. Jude,Children,s Research Hospital. The winning ...
... Colorado Youth Corps ... Association, ... and manufacturing of advanced, gradient compression equipment,and the Colorado Youth Corps ... formation of an Official,Supplier agreement., Skins(TM) will donate compression apparel ...
... of its kind in ... US ... Bulletin Board: DSCI), a company specializing in advanced wound care,today announced ... The novel dressing features a polymer-based core,that could help change the ...
... Oct. 21 When the nation,s top ... 2.0 User-Generated Healthcare conference,to showcase web technologies ... ( http://www.ThePreventionPlan.com ), a groundbreaking,health improvement program ... the,stage., (Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO ), ...
Cached Medicine News:Health News:Maria Shriver to Debut 'Night at The Village' Event with Rachael Ray, Billie Jean King, Dr. Mehmet Oz and Rocco DiSpirito 2Health News:Maria Shriver to Debut 'Night at The Village' Event with Rachael Ray, Billie Jean King, Dr. Mehmet Oz and Rocco DiSpirito 3Health News:Vista Partners Updates Coverage on MediciNova Inc. (NASDAQ: MNOV); Maintains $8.50 Price Target 2Health News:Score Big With One-of-a-Kind Swarovski Encrusted SCRABBLE(R) Board 2Health News:Score Big With One-of-a-Kind Swarovski Encrusted SCRABBLE(R) Board 3Health News:Score Big With One-of-a-Kind Swarovski Encrusted SCRABBLE(R) Board 4Health News:Colorado Youth Dressed to Compress 2Health News:Derma Sciences Announces Commercial Launch of XTRASORB(TM) 2Health News:Derma Sciences Announces Commercial Launch of XTRASORB(TM) 3Health News:U.S. Preventive Medicine(R) to Preview The Prevention Plan(TM) at National Conference for Health Care Technology Innovators 2
... The Double Bundle PCL Guides were ... femoral tunnels necessary in arthroscopic double bundle ... placement for anterolateral and posteromedial femoral tunnel ... , ,During anterolateral tunnel placement a guide ...
... The Flexible Digital Implant offers surgeons ... for the correction of a hammertoe deformity. ... grade silicone and is designed for the ... five. The Futura FDI features an anatomic ...
... of the BioPro Toe implant is to ... pain and restore motion while leaving the ... procedure used to implant the BioPro Great ... ,The design for the great toe has ...
... Electrodes share similar characteristics with ... difference is that all of ... to assist you intraoperatively. In ... for use with either our ...
Medicine Products: